The article discusses the role of CD4+CD25 T cells in idiopathic pulmonary artery hypertension (PAH). According to the article, severe PAH may occur in a subset of patients displaying systemic inflammatory conditions. It notes that idiopathic PAH patients have increased circulating CD4+CD25 regulatory T cells.